Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Soluble guanylate cyclase: the forgotten sibling
David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin hormones such as the glucagon-like peptide-1 (GLP-1) contribute to the development of hyperglycemia
Whats come about in the wake of that popularity is an entire industry of lab-created peptides, advertised and sold online, that people can use to treat themselves at home, unsupervised by health professionals
In a deal worth up to $285 million initially for the lead program, Novo Nordisk will gain access to Ascendis TransCon technology platform in an effort to find novel GLP-1 candidates with reduced dosing frequency
US$ 20.39
US$ 27.58
US$ 29.37
US$ 26.20
US$ 27.40
US$ 28.12
US$ 24.39
US$ 24.98
US$ 28.48
US$ 22.70
US$ 27.71
